prothymosin alpha is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-01. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
two DNA primers that are complementary to the 3' (three prime) ends of each of the sense and anti-sense strands of the DNA target (DNA polymerase can only bind to and elongate from a double-stranded region of DNA; without primers, there is no double-stranded initiation site at which the polymerase can bind); specific primers that are complementary to the DNA target region are selected beforehand, and are often custom-made in a laboratory or purchased from commercial biochemical suppliers deoxynucleoside triphosphates, or dNTPs, the building blocks from which the DNA polymerase synthesizes a new DNA strand a buffer solution providing a suitable chemical environment for optimum activity and stability of the DNA polymerase bivalent cations, typically magnesium (Mg) or manganese (Mn) ions; Mg2+ is the most common, but Mn2+ can be used for PCR-mediated DNA mutagenesis, as a higher Mn2+ concentration increases the error rate during DNA synthesis; and monovalent cations, typically potassium (K) ions The reaction is commonly carried out in a volume of 10–200 μL in small reaction tubes (0.2–0.5 mL volumes) in a thermal cycler. The thermal cycler heats and cools the reaction tubes to achieve the temperatures required at each step of the reaction (see below). Many modern thermal cyclers make use of a Peltier device, which permits both heating and cooling of the block holding the PCR tubes simply by reversing the device's electric current. Thin-walled reaction tubes permit favorable thermal conductivity to allow for rapid thermal equilibrium.
== Surveillance == Comparitech Limited, a UK technology advisor, published "The world's most-surveilled cities" in August 2019. It assembled data on the number of closed-circuit television (CCTV) cameras installed in 120 global cities. It then ranked the cities by number of cameras per 1,000 inhabitants. China's cities were found to be the most surveilled. Bangkok was ranked 31 (1=most surveilled; 120=least surveilled), with an estimated 53,429 cameras installed, or 5.16 cameras per 1,000 inhabitants. Other ASEAN cities were ranked: Singapore, 11 (86,000 cameras); Ho Chi Minh City, 72 (6,150 cameras); Yangon, 76 (2,995 cameras); Jakarta, 77 (6,000 cameras); Hanoi, 79 (4,400 cameras); Kuala Lumpur, 106, (1,000 cameras).
=== Demineralization === In the strict sense, the term demineralization should imply removing all dissolved "mineral species" from water. Thus not only removing dissolved salt as obtained by simple deionization, but also neutral dissolved "Mineral species" such as dissolved iron hydroxides (Fe(OH)3) or dissolved silica (Si(OH)4), two solutes often present in water. In this way, demineralized water has the same electrical conductivity as deionized water, but is purer because it does not contain non-ionized substances, i.e. neutral solutes. However, demineralized water is often used interchangeably with deionized water and can be also confused with softened water, depending on the exact definition used: removing only the cations susceptible to precipitate as insoluble minerals (from there, "demineralization"), or removing all the "mineral species" present in water, and thus not only dissolved ions but also neutral solute species. So, the term demineralized water is vague and deionized water or softened water should often be preferred in its place for more clarity.
The PRIDE (PRoteomics IDEntifications database) is a public data repository of mass spectrometry-based proteomics data, and is maintained by the European Bioinformatics Institute as part of the Proteomics Team. Originally designed by Lennart Martens in 2003 during a stay at the European Bioinformatics Institute as a Marie Curie fellow of the European Commission in the "Quality of Life" Programme (Contract number: QLRI-1999-50595), PRIDE was established as a production service in 2005. The original grant application document from June 2013 to start construction of PRIDE has since been published in a viewpoint article. Several similar proteomics databases have been built, including the GPMDB, PeptideAtlas, Proteinpedia and the NCBI Peptidome. The PRIDE database constitutes a structured data repository, and stores the original experimental data from the researchers without editorial control over the submitted data. In total, PRIDE contains data from about 60 species, the biggest fraction of it coming from human samples (including the data from the two draft human proteomes) followed by the fruit fly Drosophila melanogaster and mouse.
Sources: en.wikipedia.org
Increase in satiety leading to a reduction in energy intake Contribution to the maintenance or achievement of a normal body weight Growth or maintenance of muscle mass (compared to other protein sources) Increase in lean body mass during energy restriction and resistance training (compared to other protein sources) Reduction of body fat mass during energy restriction and resistance training (compared to other protein sources) Increase in muscle strength (compared to other protein sources) Increase in endurance capacity during the subsequent exercise bout after strenuous exercise Skeletal muscle tissue repair (compared to other protein sources) Faster recovery from muscle fatigue after exercise (compared to other protein sources). For the studies around muscle mass and strength whey protein was compared to other protein sources. This is important to note, since protein is necessary for building muscles and this study proved that whey protein is not better for building strength and size than other protein sources. On the basis of the data presented, the 2010 panel concluded that a cause and effect relationship between the consumption of whey protein and these claims had not been established.
=== Economic impact === In addition to its health impacts, obesity can lead to many problems, including disadvantages in employment and increased business costs. Research estimated the medical costs attributable to obesity in the US in 2005 at $190.2 billion or 20.6% of all medical expenditures, while the cost of obesity in Canada was estimated at CA$2 billion in 1997 (2.4% of total health costs). The total annual direct cost of overweight and obesity in Australia in 2005 was A$21 billion. Overweight and obese Australians also received A$35.6 billion in government subsidies. The estimated range for annual expenditures on diet products is $40 billion to $100 billion in the US alone. The Lancet Commission on Obesity in 2019 called for a global treaty—modelled on the WHO Framework Convention on Tobacco Control—committing countries to address obesity and undernutrition, explicitly excluding the food industry from policy development. They estimated the global cost of obesity at $2 trillion a year, about or 2.8% of world GDP. Obesity-prevention programs demonstrably reduce the cost of treating obesity-related disease. However, the longer people live, the more medical costs they incur. Analysis therefore concludes that reducing obesity may improve the public's health, but that it is unlikely to reduce health spending overall. Globally, certain countries have implemented sin taxes (such as a sugary drink tax) to curb dietary and consumer habits and to offset economic costs.
=== Pediatrics === Fever is often viewed with greater concern by parents and healthcare professionals than might be deserved, a phenomenon known as fever phobia, which is based in both caregiver's and parents' misconceptions about fever in children. Among them, many parents incorrectly believe that fever is a disease rather than a medical sign, that even low fevers are harmful, and that any temperature even briefly or slightly above the oversimplified "normal" number marked on a thermometer is a clinically significant fever. They are also afraid of harmless side effects like febrile seizures and dramatically overestimate the likelihood of permanent damage from typical fevers. The underlying problem, according to professor of pediatrics Barton D. Schmitt, is that "as parents we tend to suspect that our children's brains may melt." As a result of these misconceptions parents are anxious, give the child fever-reducing medicine when the temperature is technically normal or only slightly elevated, and interfere with the child's sleep to give the child more medicine.
James is swept into the Shadow Realm and sees a partygoer being attacked seconds before she collapses in the real world. The day after, Cordelia takes James aside and he reveals his relationship with Grace to her. Cordelia is heartbroken but happy for him. A demon attack wounds Ariadne Bridgestock and Barbara Lightwood, Thomas's oldest sister. In a flashback, James meets Grace once again. She points out that he was in love with Cordelia, which he half-heartedly denied. Later on, Grace requested him to use his shadow abilities to retrieve her Cartwright familial bracelet which Tatiana seized. A demon kept in Tatiana's greenhouse destroys it, and she blames James. Later, James reads a missive addressed to Matthew, signed by Grace. James immediately goes out alone. Jesse visits Lucie in her bedroom and informs her that James is in danger, as Grace was being followed by the Blackthorn family demon and would probably murder anyone who wasn't a Blackthorn. She goes to save James. Cordelia, Matthew and Anna Lightwood (Christopher's older sister) visit Malcolm Fade and Hypatia Vex, where they inquire about the attacks and if the downworlders might have heard of it. Cordelia saves the warlocks' lives, and in return they send for Ragnor Fell who might be able to help Cordelia. In a flashback to 1902, Thomas Lightwood had been gone for his travel year and stopped at Paris. He had met Alastair Carstairs there, and they had toured the whole city amiably. Around that time, Thomas had felt himself warming up to Alastair.
== Issues == On April 14, 2026, looksmaxxing influencer Clavicular overdosed on a Kick livestream with Androgenic, after he took a combination of the pentastack. The livestream ended, and he was rushed to the hospital. After Androgenic's pentastack video resurfaced, he defended his consumption, claiming it was less harmful than mixing alcohol with cocaine, and describing it as his: "high IQ healthy sustainable drug stack"
Sources: en.wikipedia.org
Multiple historic and cultural sites, including UNESCO World Heritage Sites, were damaged. The most affected was Chehel Sotoun and its rich ayeneh-kari. On 2 March, a strike on Arg Square damaged nearby Golestan Palace, prompting UNESCO to issue a statement of concern. On 5 March, the Azadi Sport Complex was bombed. An 8 March strike on Falak-ol-Aflak, which was marked with a blue shield emblem, damaged several sections of the site. Strikes on Isfahan on 9 March damaged Naqsh-e Jahan Square, Chehel Sotoun, Ali Qapu, the Shah Mosque, Jameh Mosque, and Teymouri Hall. On 11 March, UNESCO urged protection for Iran's heritage sites and World Heritage Sites that have been damaged or are under high risk due to the war, alongside other historic sites in Israel, Lebanon, and the rest of West Asia. On 17 March, blast waves and shrapnel damaged multiple palaces at Sa'dabad Complex in northern Tehran. Russia's Ministry of Foreign Affairs reported that strikes in Tehran on 1 April damaged the St. Nicholas Orthodox Church and its auxiliary buildings. On 7 April, the Rafi'-Nia synagogue was fully destroyed by the IAF.
== Sources == Cooper, Tom; Grandolini, Albert; Delalande, Arnaud (2015). Libyan Air Wars, Part 1: 1973-1985. Helion & Company Publishing. ISBN 978-1-909982-39-0. Cooper, Tom; Grandolini, Albert; Delalande, Arnaud (2016). Libyan Air Wars, Part 3: 1986-1989. Helion & Company Publishing. ISBN 978-1-910294-54-3. Cooper, Tom & Weinert, Peter (2010). African MiGs: Volume I: Angola to Ivory Coast. Harpia Publishing LLC. ISBN 978-0-9825539-5-4.
== Extraction and representation == On an industrial scale, diallyl disulfide is produced from sodium disulfide and allyl bromide or allyl chloride at temperatures of 40–60 °C in an inert gas atmosphere; sodium disulfide is generated in situ by reacting sodium sulfide with sulfur. The reaction is exothermic and its theoretical efficiency of 88% has been achieved in practice.
==== Pregnancy ==== The placenta produces leptin. Leptin levels rise during pregnancy and fall after childbirth. Leptin is also expressed in fetal membranes and the uterine tissue. Uterine contractions are inhibited by leptin. Leptin plays a role in hyperemesis gravidarum (severe morning sickness of pregnancy), in polycystic ovary syndrome, and hypothalamic leptin is implicated in bone growth in mice.
{\displaystyle {\begin{aligned}R_{*}&={\frac {\varepsilon }{D}}\cdot \mathrm {Re} {\sqrt {f_{\mathrm {D} }}}\cdot {\frac {1}{\sqrt {8}}}\\&={\frac {1}{2}}{\frac {\sqrt {g}}{\nu }}\varepsilon {\sqrt {S}}{\sqrt {D}}\end{aligned}}}
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.